Commercial Operations

Research and Development

Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.

Results 1 – 4 of 4 Page 1 of 1

Search results for "". Page 1 of 1, Results 1 to 4 of 4
Title	Location	Country
Title	Location	Country	Reset
Regional Lead, Market Access & Public Affairs (WESTERN CANADA ) Regional Lead, Market Access & Public Affairs (WESTERN CANADA ) Alberta ou Colombie Britanniqu, British Columbia, CA 3 Apr 2025 0.00 km	Alberta ou Colombie Britanniqu, British Columbia, CA	Canada
Personal & Administrative Assistant to Managing Director BASEE Personal & Administrative Assistant to Managing Director BASEE Athens, N/A, GR 21 Mar 2025 0.00 km	Athens, N/A, GR	Greece
Senior Manager, Global Value and Patient Access, Pipeline Senior Manager, Global Value and Patient Access, Pipeline Copenhagen, Danish Capital Region, DK 14 Apr 2025 0.00 km	Copenhagen, Danish Capital Region, DK	Denmark
Lead, Strategic Accounts, Neurology Lead, Strategic Accounts, Neurology Toronto, Ontario, CA 11 Apr 2025 0.00 km	Toronto, Ontario, CA	Canada